The Symposium is held in order to highlight and document scientifically and practically on how to prevent, diagnose and manage HIP to optimize care and outcomes in what is seen as a large knowledge gap within the field. The great success of the previous Ten DIP Symposia held all over Europe and the first in Asia-Pacific in 2016 have paved the way for the Inaugural DIPAP Greater China Symposium. Like the DIP Symposium in Europe, Greater China will aim to raise awareness of the connection between hyperglycemia and poor pregnancy outcomes, where there needs to be a greater global focus on preventing, screening, diagnosing, and managing hyperglycemia in pregnancy.
The DIP Symposium continuously aims to lead a greater global focus on Hypertension in Pregnancy (HIP), maternal and fetal medicine. Doing so by raising awareness of the links between hyperglycemia and poor maternal and fetal outcomes as well as to the future health risks to mother and offspring and demand a clearly defined global health agenda to tackle this issue. To provide guidance for testing, management and care of women with HIP regardless of resource setting as outlined in the FIGO document and to inspire action by showcasing ongoing initiatives on diabetes in pregnancy in the region and globally.